MEOH - Methanex Corp
Executive Summary
Methanex Corp is a Canadian chemicals company that produces and sells methanol and ammonia, with 10.4 million tonnes of annual methanol operating capacity and 0.3 million tonnes of annual ammonia capacity across North America, South America, the Caribbean, New Zealand, Egypt and Canada. It is one of the world's largest methanol producers and also holds a 63.1% interest in the Atlas joint venture and a 50% interest in Natgasoline.
The investment case depends on methanol prices remaining sufficiently elevated to support strong cash generation while the enlarged asset base, including OCI's international operations, integrates successfully. The next key catalyst is the Q3 2026 results and earnings call, expected after 28 October 2026, when investors will receive further evidence on production, realised pricing, capital allocation and the operating performance of the acquired assets; the principal risk is that lower methanol prices, integration problems or further impairment of the structurally challenged Trinidad operations overwhelm operating gains.
OPPORTUNISTIC BUY. Conviction Score: 53/100. A sustained recovery in realised methanol prices, clean integration of OCI and no further material Trinidad impairments would strengthen the view, while prolonged methanol-price weakness or another significant write-down would undermine it.
Thesis break: Further material Trinidad impairment, failure to secure viable Titan natural gas economics, or a material deterioration in cash generation or leverage following the OCI integration would invalidate the investment thesis regardless of the share price.
Business Model
Methanex generates revenue principally by selling methanol into the global chemical and energy markets, with additional revenue from ammonia and from marine logistics through its majority-owned Waterfront Shipping subsidiary. The business is exposed to the methanol price cycle as well as differences in regional feedstock costs, freight rates, plant reliability and supply availability; accordingly, revenue and margins can change materially even when sales volumes remain comparatively stable.
The group's operating footprint comprises wholly owned and joint-venture methanol plants in the US, Chile, Trinidad and Tobago, New Zealand and Egypt, the Medicine Hat plant in Canada, and a 50% interest in Natgasoline. Methanex also owns a low-carbon methanol production and marketing business acquired with OCI, while two New Zealand operations have been idled indefinitely.
Its competitive advantages are scale, access to feedstock, global logistics capability and the ability to operate production across multiple regions, but these do not eliminate commodity cyclicality. Q2 2026 illustrates the operating leverage: net income attributable to shareholders was USD198 million, Adjusted EBITDA was USD577 million and the average realised methanol price rose to USD529 per tonne from USD351 per tonne in Q1 2026. The company also reported USD300 million of Adjusted net income for the quarter.
Financial Snapshot
Recent Catalysts
[28 July 2026] - Methanex reported record North American production and second-quarter 2026 earnings, including net income attributable to shareholders of USD198 million, Adjusted EBITDA of USD577 million and Adjusted net income of USD300 million. The average realised methanol price increased to USD529 per tonne from USD351 per tonne in the first quarter. Source: Methanex Q2 2026 news release and Form 6-K.
[29 June 2026] - Methanex provided an operational update that included the indefinite idling of its 860,000-tonne-per-year Titan methanol plant in Trinidad and Tobago after the company was unable to agree a new natural gas contract. Source: Methanex investor relations update.
[27 June 2025] - Methanex completed its acquisition of OCI Global's international methanol business for approximately USD2.05 billion, adding international production, ammonia capacity, the Natgasoline interest and low-carbon methanol activities. The finalised consideration included USD1.18 billion in cash, 9.9 million newly issued Methanex shares and assumed debt and leases. Source: Methanex 2025 Annual Report.
[28 July 2026] - Methanex's second-quarter 2026 MD&A disclosed USD191 million of pre-tax asset impairments, including exposure associated with the company's Trinidad operations and natural gas contract position. Source: Methanex Q2 2026 MD&A, Note 2.
[15 July 2026] - Methanex announced a quarterly cash dividend of USD0.185 per common share, reinforcing the company's willingness to return capital alongside debt management and integration spending. Source: Methanex notice of cash dividend.
Thesis Evaluation
Bull Case (18% weight)
Methanol realised prices remain close to or above the Q2 2026 level of USD529 per tonne, North American production remains at record levels and OCI integration generates cash without material disruption. Adjusted EBITDA remains near USD577 million per quarter or improves, supporting a 12-month price target of $71, broadly consistent with the publicly cited analyst target range near USD71.
Base Case (52% weight)
Methanol pricing normalises from the second-quarter peak, but improved North American output, the enlarged asset portfolio and Waterfront Shipping partly offset the decline. Adjusted EBITDA moderates from USD577 million as the company works through integration and Trinidad restructuring, producing a 12-month price target of $64, close to the current USD63.75 price.
Bear Case (30% weight)
Methanol prices weaken materially, the Titan idling and other Trinidad constraints lead to further impairments, or OCI integration produces unexpected costs and weaker cash conversion. The share price falls to $42 over 12 months as earnings estimates decline and the balance-sheet benefits from the acquisition fail to materialise.
Key Risks
- Methanol price cyclicality: A sustained decline in global methanol prices would reduce realised pricing and EBITDA from the USD577 million reported in Q2 2026. Estimated probability: 35%. Impact: severe.
- Trinidad operational and impairment risk: Titan has been idled indefinitely following the inability to agree a new natural gas contract, while the Q2 2026 MD&A disclosed USD191 million of pre-tax impairments. Estimated probability: 30%. Impact: severe.
- OCI integration execution: Failure to integrate the acquired international methanol and ammonia operations at the expected cost or generate the anticipated cash flows could weaken returns on the approximately USD2.05 billion transaction. Estimated probability: 25%. Impact: moderate.
- Plant reliability and feedstock constraints: Unplanned outages or unfavourable natural gas economics across the enlarged production footprint could prevent the group from sustaining record North American output and realise weaker margins. Estimated probability: 25%. Impact: moderate.
- Leverage and capital allocation: Cash obligations associated with the OCI acquisition, integration spending, dividends and restructuring could constrain balance-sheet flexibility if operating cash flow declines. Estimated probability: 20%. Impact: moderate.
- Revenue concentration in commodity chemicals: A concentration of earnings in methanol leaves Methanex exposed to changes in industrial demand, global supply, freight costs and customer production schedules. Estimated probability: 25%. Impact: moderate.
Who Should Own It / Avoid It
Ideal for: investors who understand commodity-chemical cyclicality, tolerate material earnings and share-price volatility and can hold the position for at least 12 months. The opportunity suits investors seeking exposure to methanol pricing and operating leverage, provided they monitor the integration of OCI, North American production, leverage and the performance of the Trinidad assets rather than treating Methanex as a conventional defensive chemicals holding.
Avoid if: investors require stable earnings, limited drawdowns, predictable cash distributions or low commodity sensitivity. It is unsuitable for those unwilling to tolerate a potential fall to USD42 in the bear scenario or those whose investment case depends on immediate completion of the acquired assets' integration.
Recommendation
OPPORTUNISTIC BUY - 53/100. The completed OCI acquisition, record North American production and strong Q2 2026 execution justify an opportunistic buying stance, but the elevated valuation and exposure to methanol prices, Trinidad impairments and integration risk prevent a higher-conviction rating. An upgrade would require sustained realised methanol pricing near the Q2 2026 level, continued record output, successful integration and clearer evidence that the Trinidad restructuring is contained. The rating would be degraded by further material impairments, weaker cash conversion, increased leverage or a sustained fall in methanol realised prices. At the current price of $70.11 the shares trade at or above our base-case target of $64.00: the base case is fully priced, existing holders should consider trimming, and new positions are not advised above $49.33.
The probability-weighted value across our three scenarios is $58.66, 16% below the current price of $70.11 - the market is currently pricing the shares ahead of our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.
below $49.33 - below this level the upside to the base-case target ($64.00) is at least 2x the downside to the bear case ($42.00), the minimum risk/reward we require before committing new capital.
between $49.33 and $64.00 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.
above $64.00 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 18%.
if further material Trinidad impairment, failure to secure viable Titan natural gas economics, or a material deterioration in cash generation or leverage following the OCI integration would invalidate the investment thesis regardless of the share price, regardless of price - the bear target of $42.00 is the backstop, not an arbitrary percentage stop.
Conviction Trend
Latest conviction: 53/100. Trend versus prior report: Initiation.
| Report date | Conviction |
|---|---|
| 2026-10-28 | 53 |
Sources
Market data: DYOR HQ proprietary market data workflow.
Public sentiment and news flow: Public company earnings releases, regulatory filings, investor-relations materials, financial-news reporting and analyst commentary were used to assess the completed OCI acquisition, Q2 2026 performance, dividend declarations, Titan idling and market expectations.
Primary source types: SEC Form 6-K filings, Methanex quarterly news releases and MD&A, annual-report disclosure, investor-relations announcements, regulatory announcements and public earnings-call materials.
Key sources
- Methanex Reports Record North American Production and Second Quarter 2026 Earnings - Methanex | Methanex
- Methanex Corporation (MEOH) Q4 FY2025 earnings call transcript
- Methanex: MEOH Stock Price Quote & News | Robinhood
- Methanex Corporation (MEOH) Stock Price, News, Earnings & Company Profile
- Methanex (MEOH) Stock Price, News & Analysis
- Methanex (MEOH) Stock Price, News & Analysis
- Methanex (MEOH) Stock News & Updates | StockTitan
- Methanex (MEOH) Stock Forecast: Analyst Ratings, Predictions & Price Target 2026
- Methanex (MEOH) Stock Price & Overview
- Methanex (MEOH) Q1 2026 Earnings Transcript | The Motley Fool
Analysis generated 2026-10-28. Market data as of 2026-11-12.